Wisconsin Pro-Life Group Concerned Telemed Abortions Coming There
by Steven Ertelt
June 16, 2010
Madison, WI (LifeNews.com) — The new telemed abortion process Planned Parenthood has started so far in Iowa and it has pro-life advocates up in arms because it puts women at risk by now allowing them a chance to visit with a physician before getting the dangerous drug. Now, there’s concern the process may be coming to Wisconsin.
The abortion drug already presents significant concerns for women as at least 13 women worldwide, and potentially dozens more, have died from using the mifepristone abortion drug.
FDA figures reveal another 1,100, as of 2006, have been injured by it and have required hospitalization and blood transfusions because of the problems.
The FDA recommends the drug only be given after consulting with a physician. To save money by not bringing in an abortion practitioner to meet with women getting the abortion drug, Planned Parenthood is forcing women to "meet" with a physician only by videoconference.
Currently, Planned Parenthood of Wisconsin dispenses birth control via teleconferencing. The abortion business uses the process at 10 locations, which Pro-Life Wisconsin says is because they are the organizations Title X clinics and receive funding from the federal government.
Tax dollars financed the setup of PPWI’s teleconferencing system, the Milwaukee Business Journal recently reported.
PPWI has the videoconference infrastructure in place to dispense hormonal birth control, including the morning after pill," Virginia Zignego, communications director for the pro-life group, told LifeNews.com.
She said, "There doesn’t appear to be anything in Wisconsin law or code that would hold them back from using videoconferencing to dispense mifepristone, the medicine formerly known as RU-486, which is designed to cause post-implantation chemical abortions.
Zignego is concerned women won’t be told about the problems and noted that the FDA released public documents to Concerned Women of America listing over 600 adverse effects of women taking this drug. These included 220 cases of hemorrhage that were either life-threatening or extremely serious, 71 of which required blood transfusions.
Women taking mifepristone typically bleed for one to two weeks, with 10% bleeding for more than one month. The average woman loses four times the amount of blood from a standard surgical abortion, she noted.
Mifepristone is a toxic substance hazardous to womens health, said Zignego. Several deaths have been attributed to mifepristone. Its prescription and use ought to be highly restricted, if not banned.
Sign Up for Free Pro-Life News From LifeNews.com
Daily Pro-Life News Report Twice-Weekly Pro-Life
News Report Receive a free daily email report from LifeNews.com with the latest pro-life news stories on abortion, euthanasia and stem cell research. Sign up here. Receive a free twice-weekly email report with the latest pro-life news headlines on abortion, euthanasia and stem cell research. Sign up here.